Merck KGaA is bolstering its drug discovery efforts by turning to 2 synthetic intelligence firms, BenevolentAI and Exscientia. Particulars are...
discovery
In a current examine printed in Nature, researchers investigated whether or not glutamatergic gliotransmission was mediated by specialised astrocytes within...
